{"id":"W4248668221","doi":"10.1158/1538-7445.sabcs18-p6-18-34","title":"Abstract P6-18-34: Treat ER+ight Canadian prospective observational study in HR+ advanced breast cancer: <i>3rd interim analysis</i>","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Novartis (Canada); Lions Gate Hospital; Windsor Regional Hospital; Saskatchewan Cancer Agency; BC Cancer Agency; Kingston General Hospital; Ottawa Hospital; North York General Hospital","funders":"","keywords":"Medicine; Palbociclib; Exemestane; Fulvestrant; Letrozole; Everolimus; Internal medicine; Interim analysis; Breast cancer; Oncology; Adverse effect; Cancer; Anastrozole; Discontinuation; Metastatic breast cancer; Hazard ratio; Tamoxifen; Clinical trial; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003539772,0.0006794999,0.001091346,0.0005409595,0.001488239,0.001316902,0.0009526387,0.0006567242,0.007919339],"category_scores_gemma":[0.003302276,0.0003979615,0.002620644,0.0009908547,0.0004454907,0.0004039644,0.0006857759,0.001654535,0.00115783],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003922969,"about_ca_system_score_gemma":0.009363186,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.2779062,"about_ca_topic_score_gemma":0.4424203,"domain_scores_codex":[0.9982706,0.0003232478,0.00007182021,0.0002317863,0.0006940878,0.0004082963],"domain_scores_gemma":[0.9977748,0.0001941957,0.0004447511,0.0003891551,0.0007558992,0.0004412636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1577379,0.001955339,0.5628683,0.001022256,0.007849701,0.0003473107,0.0003309646,0.00259669,0.005035263,0.001506091,0.204336,0.05441414],"study_design_scores_gemma":[0.02702896,0.005557713,0.8972145,0.0002025329,0.004108252,0.0002222411,0.0001593252,0.001346768,0.001693546,0.0005406449,0.06182472,0.0001006602],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5591674,0.002882638,0.004330927,0.002394345,0.0004392817,0.007455059,0.4022307,0.0004609151,0.02063883],"genre_scores_gemma":[0.7141176,0.0008601871,0.007765442,0.002671011,0.0002468678,0.01074835,0.2474872,0.0001830234,0.01592031],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7220938,"threshold_uncertainty_score":0.5525773,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1255229857327304,"score_gpt":0.4553104924355075,"score_spread":0.329787506702777,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}